SCHEMBL4454484

SCHEMBL4454484

CON1C(=O)OC(C)(C)C1(OC)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.34
LPL P06858 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
MMP2 P08253 2/20 0.33
MMP9 P14780 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MMP3 P08254 1/20 0.33
KMT2A Q03164 1/20 0.32
BACE1 P56817 1/20 0.31
FAAH O00519 4/20 0.31
MGLL Q99685 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
MMP1 P03956 1/20 0.30
ADAM17 P78536 1/20 0.30
EDNRA P25101 1/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4454486 0.75 GAA (0.35) HSD11B1KDM4EHPGDMMP2MMP9
SCHEMBL4480090 0.67 HSD11B1 (0.36) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4450100 0.67 HSD11B1 (0.37) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4450103 0.61 GAA (0.40) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4480093 0.61 ELANE (0.38) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4454824 0.59 GRM2 (0.40) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4458256 0.59 IDH1 (0.39) HSD11B1MMP2MMP9ALDH1A1MMP3
SCHEMBL6932927 0.58 CHRNA1 (0.42) LPLLIPGKDM4EHPGDMMP2
SCHEMBL28376028 0.56 ALDH1A1 (0.45) LPLLIPGMMP2MMP9ALDH1A1
Biphenyl SCHEMBL3908169 0.56 ALDH1A1 (0.69) ALDH1A1MMP3KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 HSD11B1 945/4885LPL 966/4885LIPG 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.